Bonesupport Holding AB (CHIX:BONEXS) OCF Yield %: 1.70 (As of Jul. 09, 2026)


CHIX:BONEXS Bonesupport Holding AB CHIX:BONEXS
77 GF Score
Price kr229.60
GF Value kr417.39
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB OCF Yield %?

Bonesupport Holding AB CHIX:BONEXS 77 OCF Yield % is 1.70 as of Jul. 09, 2026. GuruFocus rates CHIX:BONEXS with a GF Score™ of 77/100 and a GF Value™ of kr417.39 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Bonesupport Holding AB ranks worse than 50.12% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Bonesupport Holding AB's Trailing 12-Month Cash Flow from Operations is kr250 Mil, and Market Cap is kr14,669 Mil. Therefore, Bonesupport Holding AB's OCF Yield % for today is 1.70%.

The historical rank and industry rank for Bonesupport Holding AB's OCF Yield % or its related term are showing as below:

CHIX:BONEXs' s OCF Yield % Range Over the Past 10 Years
Min: -26.06   Med: -2.06   Max: 1.99
Current: 1.7


During the past 12 years, the highest OCF Yield % of Bonesupport Holding AB was 1.99%. The lowest was -26.06%. And the median was -2.06%.

CHIX:BONEXs's OCF Yield % is ranked worse than
50.12% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 1.705 vs CHIX:BONEXs: 1.70

Bonesupport Holding AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Bonesupport Holding AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Bonesupport Holding AB OCF Yield % Related Terms


Bonesupport Holding AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB OCF Yield % Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.98 -0.91 -0.19 0.31 1.78

Bonesupport Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 1.07 1.46 1.73 2.39

CHIX:BONEXS vs ISRG, BDX, MDLN: OCF Yield % Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's OCF Yield % falls into.


CHIX:BONEXS
77GF Score
Bonesupport Holding AB CHIX:BONEXS
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Bonesupport Holding AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=221.304 / 12457.22985
=1.78%

Bonesupport Holding AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=74.929 * 4 / 12516.50295
=2.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 1.70 mean?
Bonesupport Holding AB (CHIX:BONEXS) has a OCF Yield % of 1.70 as of Jul. 09, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bonesupport Holding AB and its competitors. According to the industry distribution chart, Bonesupport Holding AB ranks #427 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Bonesupport Holding AB's OCF Yield % too high?
Bonesupport Holding AB's current OCF Yield % is 1.70. The Medical Devices & Instruments industry median OCF Yield % is 1.71. Bonesupport Holding AB's value of 1.70 is 0.3% below this industry median. Based on the distribution chart, Bonesupport Holding AB ranks #427 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bonesupport Holding AB has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #427 out of 852 companies for OCF Yield %. This places Bonesupport Holding AB in the lower half of its industry. The industry median OCF Yield % is 1.71. Bonesupport Holding AB's value of 1.70 is 0.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.71, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonesupport Holding AB's current OCF Yield % of 1.70 is 0.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current OCF Yield % is 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (CHIX:BONEXS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr417.39, compared to a current price of kr229.60 — trading 45% below its estimated fair value. The current OCF Yield % is 1.70 and 0.3% below the Medical Devices & Instruments industry median of 1.71. Bonesupport Holding AB's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bonesupport Holding AB (CHIX:BONEXS), the current OCF Yield % is 1.70 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (CHIX:BONEXS) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of kr229.60 is trading 45% below its estimated GF Value™ of kr417.39. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for CHIX:BONEXS:

  • OCF Yield %: 1.70
  • GF Value™: kr417.39 vs. price of kr229.60 (45% below fair value)
  • GF Score™: 77/100 with 2 warning signs
  • Industry Position: 0.3% below the Medical Devices & Instruments median (#427 of 852)

No single metric tells the full story. See the CHIX:BONEXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
77GF Score

Get the complete analysis for CHIX:BONEXS

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr229.60
Price
kr417.39
GF Value